Showing results (151-160 of 205) with videos related to
Sort By:
Pageof 21
The Journal of Pathology|March 13, 1998
The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissueL C Happerfield, D W Miles, D M Barnes, et al.International Journal of Cancer|March 12, 1998
Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parametersE A Dublin, N K Patel, C E Gillett, et al.Journal of Human Evolution|November 7, 2006
Molar development in common chimpanzees (Pan troglodytes)T M Smith, D J Reid, M C Dean, et al.Cancer Research|January 1, 1987
Endocrine therapy for advanced carcinoma of the breast: effect of tumor heterogeneity and site of biopsy on the predictive value of progesterone receptor estimationsA Howell, R N Harland, D M Barnes, et al.Oncogene|April 17, 1997
Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like familyM E Lomax, D M Barnes, R Gilchrist, et al.British Journal of Cancer|April 1, 1993
Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cellsR S Camplejohn, A Brock, D M Barnes, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?D M Barnes, J Bartkova, R S Camplejohn, et al.British Journal of Cancer|March 1, 1991
The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancerS M O'Reilly, D M Barnes, R S Camplejohn, et al.British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10G D Wilson, R S Camplejohn, C A Martindale, et al.Pageof 21